RAD-140, commonly known as Testolone, has been widely investigated in preclinical research for its strong binding affinity to androgen receptors. Studies have explored how RAD-140 interacts with muscle and bone tissue models while demonstrating reduced interaction with non-target tissues in controlled settings.

Experimental data suggests RAD-140 has attracted attention due to its receptor selectivity profile. Research has explored its potential role in studies examining lean mass signaling, neuromuscular pathways, and androgen-responsive tissues, strictly within laboratory and animal research environments.

This liquid RAD-140 formulation is developed for research consistency and analytical precision. Each batch undergoes quality control processes designed to verify identity, concentration, and stability, supporting reproducible laboratory work.

RAD-140 is supplied strictly as a research compound. It is not approved for human use, is not a dietary supplement, and is not intended for consumption. All references to effects are based solely on experimental and preclinical research findings.